Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Healthy Extracts (HYEX) EBIAT (2016 - 2025)

Healthy Extracts' EBIAT history spans 11 years, with the latest figure at $20.1 million for Q4 2025.

  • For Q4 2025, EBIAT rose 4.58% year-over-year to $20.1 million; the TTM value through Dec 2025 reached $19.4 million, up 2.9%, while the annual FY2025 figure was -$881119.0, 4.81% down from the prior year.
  • EBIAT reached $20.1 million in Q4 2025 per HYEX's latest filing, up from -$395394.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $20.1 million in Q4 2025 to a low of -$1.3 million in Q1 2021.
  • Average EBIAT over 5 years is $2.6 million, with a median of -$209073.5 recorded in 2022.
  • The largest YoY upside for EBIAT was 42132.92% in 2023 against a maximum downside of 19334.71% in 2023.
  • A 5-year view of EBIAT shows it stood at $536735.0 in 2021, then tumbled by 91.91% to $43417.0 in 2022, then soared by 42132.92% to $18.3 million in 2023, then increased by 4.93% to $19.2 million in 2024, then rose by 4.58% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for HYEX's EBIAT are $20.1 million (Q4 2025), -$395394.0 (Q3 2025), and $67120.0 (Q2 2025).